Citi analyst Joanne Wuensch lowered the firm’s price target on Insulet to $273 from $319 and keeps a Neutral rating on the shares post the Q2 report. The analyst says tough compares and a GLP-1 “overhang on an expensive stock” keeps it on the sidelines.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PODD: